quantisnow
FeedTopReportsPricing
⌘K
Live feed
17:07:32·807d
SECFiling
Invitae Corporation logo

Invitae Corporation filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

NVTA· Invitae Corporation
Health Care
Original source

Companies

  • NVTA
    Invitae Corporation
    Health Care

Recent analyst ratings

  • Jul 5UpdateJP Morgan-
  • May 15UpdateRaymond James-
  • Jan 31UpdateGoldman$2.00
  • Aug 25UpdateCredit Suisse$1.00
  • Aug 10UpdateJP Morgan-
  • Jul 26UpdateCowen$2.50

Related

  • PR252d
    Citizen Health Raises $30 Million to Build AI Advocate for Every Patient, Ushering in a New Era of Patient-Centered Healthcare
  • NEWS728d
    Labcorp's Q1 Revenue Surpasses Forecasts; Analysts Scrutinize Invitae Deal
  • NEWS728d
    Reported Earlier, Labcorp Wins Bid For Invitae Assets To Boost Specialty Testing In Oncology And Rare Diseases
  • PR729d
    Labcorp Announces Winning Bid for Select Assets of Invitae
  • PR729d
    Invitae Enters into Agreement with Labcorp for Sale of Business
  • PR731d
    Invitae Publishes its Environmental, Social and Governance (ESG) Report
  • PR742d
    Invitae Unveils New Research for Breast Cancer Patients with Variants of Uncertain Significance
  • PR772d
    Invitae Launches Update to Invitae Generation™: Clinical Variant Modeling Improves Variant Classification
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022